|
EIF1AX expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.96309999999489E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.804100E-03 |
| Normal-vs-Stage2 |
2.082000E-02 |
| Normal-vs-Stage3 |
1.91749999999269E-05 |
| Normal-vs-Stage4 |
1.86037999999611E-05 |
| Stage1-vs-Stage2 |
5.012000E-01 |
| Stage1-vs-Stage3 |
1.964270E-02 |
| Stage1-vs-Stage4 |
1.902240E-02 |
| Stage2-vs-Stage3 |
3.508000E-01 |
| Stage2-vs-Stage4 |
3.801400E-01 |
| Stage3-vs-Stage4 |
9.700800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.378520E-04 |
| Normal-vs-AfricanAmerican |
2.01639999999337E-05 |
| Normal-vs-Asian |
5.078000E-01 |
| Caucasian-vs-AfricanAmerican |
8.128400E-02 |
| Caucasian-vs-Asian |
5.527800E-01 |
| AfricanAmerican-vs-Asian |
1.513420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.02962083303737E-12 |
| Normal-vs-Female |
3.324200E-01 |
| Male-vs-Female |
1.62447832963153E-12 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.084950E-03 |
| Normal-vs-Age(41-60Yrs) |
1.822170E-04 |
| Normal-vs-Age(61-80Yrs) |
1.964520E-03 |
| Normal-vs-Age(81-100Yrs) |
7.539600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.781200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.465600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.615400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.615800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.510000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.366600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.868000E-01 |
| Normal-vs-Grade 2 |
1.813570E-01 |
| Normal-vs-Grade 3 |
4.28239999017421E-09 |
| Normal-vs-Grade 4 |
4.41009451179752E-11 |
| Grade 1-vs-Grade 2 |
6.389000E-01 |
| Grade 1-vs-Grade 3 |
7.716500E-03 |
| Grade 1-vs-Grade 4 |
9.69020000000098E-05 |
| Grade 2-vs-Grade 3 |
1.88530000000409E-06 |
| Grade 2-vs-Grade 4 |
2.40419995023444E-09 |
| Grade 3-vs-Grade 4 |
2.571500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.582600E-01 |
| Normal-vs-ccB subtype |
8.17320000012778E-07 |
| ccA subtype-vs-ccB subtype |
5.83699999999743E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.410500E-04 |
| Normal-vs-N1 |
4.117000E-03 |
| N0-vs-N1 |
2.892800E-01 |
|
|
